Form 4 for CARL CARLSMED, INC.
Accepted 2026-03-04 00:00:00 ET · period of report 2026-03-02 · accession 0001193125-26-091468 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-04 | 2026-03-02+ | CARL | Cordonnier Michael | CEO, Pres, Dir | M - OptEx | $0.6805 | +391.7K | 1.52M | +35% | +$266.6K |
| D | 2026-03-04 | 2026-03-02 | CARL | Cordonnier Michael | CEO, Pres, Dir | S - Sale+OE | $13.29 | -197.9K | 1.36M | -13% | -$2.63M |
| DM | 2026-03-04 | 2026-03-02+ | CARL | Cordonnier Michael | CEO, Pres, Dir | M - OptEx | $0.00 | -391.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-02 | M | A | 197,855 | $0.34 | 1,554,501 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-03 | M | A | 33,264 | $4.35 | 1,550,477 | D | — | — | |
| 3 | Common | Common Stock | 2026-03-03 | M | A | 160,567 | $0.34 | 1,517,213 | D | — | — | |
| 4 | Common | Common Stock | 2026-03-02 | S | D | 197,855 | $13.29 | 1,356,646 | D | — | — | (F1) Sale of shares to cover the exercise price, withholding tax obligations and broker fees and commissions, pursuant to a broker assisted cashless exercise of vested stock options granted on January 8, 2021 and February 19, 2025 under the Carlsmed, Inc. 2019 Stock Incentive Plan. (F2) This transaction was executed in multiple trades at prices ranging from $13.000 to $14.030. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-03-03 | M | D | 33,264 | $0.00 | 191,692 | D | $4.35 · — to 2035-02-18 | 33,264 Common Stock | (F4) 25% of the shares underlying these options, representing a right to purchase a total of 224,956 shares, vested and became exercisable on December 15, 2025, with the remaining shares vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. |
| 6 | Derivative | Stock Option (Right to Buy) | 2026-03-02 | M | D | 197,855 | $0.00 | 160,567 | D | $0.34 · — to 2031-01-07 | 197,855 Common Stock | (F3) 25% of the shares underlying these options, representing a right to purchase a total of 358,422 shares, vested and became exercisable on December 15, 2021, with the remaining shares vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. |
| 7 | Derivative | Stock Option (Right to Buy) | 2026-03-03 | M | D | 160,567 | $0.00 | 0 | D | $0.34 · — to 2031-01-07 | 160,567 Common Stock | (F3) 25% of the shares underlying these options, representing a right to purchase a total of 358,422 shares, vested and became exercisable on December 15, 2021, with the remaining shares vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. |